Invention Grant
- Patent Title: Cell-penetrating peptides having a central hydrophobic domain
- Patent Title (中): 具有中枢疏水结构域的细胞穿透肽
-
Application No.: US14240832Application Date: 2012-08-29
-
Publication No.: US09302014B2Publication Date: 2016-04-05
- Inventor: Michael John Gait , Andrey Alexandrovich Arzumanov , Amer F. Saleh , Matthew J. A. Wood , Corinne Betts , Taeyoung Koo
- Applicant: Michael John Gait , Andrey Alexandrovich Arzumanov , Amer F. Saleh , Matthew J. A. Wood , Corinne Betts , Taeyoung Koo
- Applicant Address: GB Swindon
- Assignee: Medical Research Council
- Current Assignee: Medical Research Council
- Current Assignee Address: GB Swindon
- Agency: Swanson & Bratschun, L.L.C.
- Priority: GB1115014.1 20110830; GB1211740.4 20120703
- International Application: PCT/GB2012/052116 WO 20120829
- International Announcement: WO2013/030569 WO 20130307
- Main IPC: C07K14/08
- IPC: C07K14/08 ; A61K38/10 ; A61K47/48 ; C07K7/02 ; C07K14/00 ; C12N15/00 ; A61K38/16 ; C07K7/08

Abstract:
The present invention discloses cell penetrating peptides (CPP or membrane translocating peptide) and their conjugates with cargo molecules. The peptides are useful as drug delivery systems, particularly as delivery vehicles for nucleotide-based therapeutics, such as polynucleotides, oligonucleotides and peptide nucleic acids. A CPPs of the invention provides a balance between good cell entry efficiency and low toxicity and comprises three contiguous domains: the central one being hydrophobic and the flanking ones consisting of arginine and aminohexanoic acid or beta-alanine residues. The hydrophobic domain contains a sequence selected from YQFLI, YRFLI, IQFLI and IRFLI.
Public/Granted literature
- US20140342992A1 Cell-Penetrating Peptides Having a Central Hydrophobic Domain Public/Granted day:2014-11-20
Information query